Evelyn V. Moreno’s Nomura Holdings NMR Stock Holding History

Evelyn V. Moreno’s Portfolio NMR Stock Details NMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$396K	Hold	87,744	–	–	0.19%	85
2023 Q3	$353K	Hold	87,744	–	–	0.08%	98
2023 Q2	$336K	Hold	87,744	–	–	0.07%	86
2023 Q1	$333K	Hold	87,744	–	–	0.08%	87
2022 Q4	$329K	Buy	+87,744	New	+$303K	0.08%	128
2022 Q2	–	Sell	-19,307	Closed	-$81K	–	162
2022 Q1	$81K	Buy	+19,307	New	+$87.2K	0.02%	105

Other funds holding NMR

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ethic Inc New York $6.39B AUM 29.64% 1-Year Est. Return

Evelyn V. Moreno's NMR Position: Q4 2023 in Review

Evelyn V. Moreno held its Nomura Holdings (NMR) position steady in Q4 2023 at 87,744 shares worth $396K. The position accounts for 0.19% of the portfolio, ranked #85.

Evelyn V. Moreno first reported a position in NMR in Q1 2022 and has held it in 6 quarters since. 150 funds tracked by Wall St. Rank hold NMR as of Q4 2023.

Evelyn V. Moreno held 87,744 shares of Nomura Holdings worth $396K as of Q4 2023.
Evelyn V. Moreno left its Nomura Holdings share count unchanged in Q4 2023.
Nomura Holdings made up 0.19% of Evelyn V. Moreno's portfolio in Q4 2023, its #85 holding.
Evelyn V. Moreno first reported a position in Nomura Holdings in Q1 2022 and has held it in 6 quarters since.
150 funds tracked by Wall St. Rank held Nomura Holdings as of Q4 2023.

Based on Evelyn V. Moreno's 13F filing for Q4 2023, filed 9 Feb 2024.